Zobrazeno 1 - 10 of 433 pro vyhledávání: '"Richard B Lanman"'
1
Akademický článek
Ancient DNA analysis of archaeological specimens extends Chinook salmon's known historic range to San Francisco Bay's tributaries and southernmost watershed.
Autor: Richard B Lanman, Linda Hylkema, Cristie M Boone, Brian Allée, Roger O Castillo, Stephanie A Moreno, Mary Faith Flores, Upuli DeSilva, Brittany Bingham, Brian M Kemp
Publikováno v: PLoS ONE, Vol 16, Iss 4, p e0244470 (2021)
Understanding a species' historic range guides contemporary management and habitat restoration. Chinook salmon (Oncorhynchus tshawytscha) are an important commercial and recreational gamefish, but nine Chinook subspecies are federally threatened or e
Externí odkaz: https://doaj.org/article/28174bc281c846fd934fa14769c12fd1
Zobrazit plný text záznamu
2
Akademický článek
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors
Autor: David E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, Kimberly C Banks, Najee Boucher, Garni Barkhoudarian, Daniel F Kelly, Tiffany Juarez, Richard B Lanman, Victoria M Raymond, Minhdan Nguyen, Judy D Truong, Annie Heng, Jaya Gill, Marlon Saria, Sandeep C Pingle, Santosh Kesari
Publikováno v: CNS Oncology, Vol 8, Iss 2 (2019)
Aim: Genomically matched trials in primary brain tumors (PBTs) require recent tumor sequencing. We evaluated whether circulating tumor DNA (ctDNA) could facilitate genomic interrogation in these patients. Methods: Data from 419 PBT patients tested cl
Externí odkaz: https://doaj.org/article/ef6262da7ada4d6092de61d74bc2de20
Zobrazit plný text záznamu
3
Akademický článek
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.
Autor: Richard B Lanman, Stefanie A Mortimer, Oliver A Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A Collisson, Stephen G Divers, Dave S B Hoon, E Scott Kopetz, Jeeyun Lee, Petros G Nikolinakos, Arthur M Baca, Bahram G Kermani, Helmy Eltoukhy, AmirAli Talasaz
Publikováno v: PLoS ONE, Vol 10, Iss 10, p e0140712 (2015)
Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively parallel and deep sequencing enables assessment of a comprehensive panel of genomic targets from
Externí odkaz: https://doaj.org/article/133fc4af39b34633abd205b896147ca3
Zobrazit plný text záznamu
4
Akademický článek
Habitat suitability assessment for tule elk in the San Francisco Bay and Monterey Bay areas
Autor: Thomas Connor, Thomas J. Batter, Cristen O. Langner, Jeff Cann, Cynthia McColl, Richard B. Lanman
Publikováno v: California Fish and Wildlife Journal, Vol 109, Iss 4 (2023)
While California’s statewide tule elk (Cervus canadensis nannodes) population has recovered from two or three individual survivors in the late 19th century, the subspecies exists today in numerous widely disjunct populations, leaving vast areas of
Externí odkaz: https://doaj.org/article/cbcea1f6d1c447df892afd3dcd654bd7
Zobrazit plný text záznamu
5
Akademický článek
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
Autor: Stephen R. Fairclough, Lesli A. Kiedrowski, Jessica J. Lin, Ori Zelichov, Gabi Tarcic, Thomas E. Stinchcombe, Justin I. Odegaard, Richard B. Lanman, Alice T. Shaw, Rebecca J. Nagy
Publikováno v: Experimental Hematology & Oncology, Vol 8, Iss 1, Pp 1-6 (2019)
Abstract Cell-free DNA (cfDNA) next-generation sequencing has the potential to capture tumor heterogeneity and genomic evolution under treatment pressure in a non-invasive manner. Here, we report the detection of EGFR L792 mutations, a non-covalent m
Externí odkaz: https://doaj.org/article/a2642d01b2c14be0a9b216a7597b136a
Zobrazit plný text záznamu
6
Akademický článek
Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Autor: Jeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, Seung Tae Kim, Kyoung-Mee Kim, Kimberly C. Banks, Victoria M. Raymond, Richard B. Lanman
Publikováno v: Frontiers in Oncology, Vol 9 (2019)
Background: HER2 antagonists have marked activity and are approved for the treatment of HER2 overexpressing breast and gastric cancers. Recent studies have shown that ERBB2 (HER2) gene amplification and overexpression may also be actionable in other
Externí odkaz: https://doaj.org/article/9d77b0f9e0ba4618b2c746f3664aef09
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje